Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 164 (3), 1198-1205
- https://doi.org/10.1016/0006-291x(89)91796-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- What is the relationship between the endothelium derived relaxant factor and nitric oxide?Life Sciences, 1989
- Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxideBiochemical and Biophysical Research Communications, 1989
- Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbitBritish Journal of Pharmacology, 1989
- Biosynthesis of nitric oxide from l-arginineBiochemical Pharmacology, 1989
- Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: Requirement for inducible and constitutive componentsBiochemical and Biophysical Research Communications, 1989
- L-Arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxationBiochemical and Biophysical Research Communications, 1989
- A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxationBritish Journal of Pharmacology, 1989
- A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation.Journal of Clinical Investigation, 1988